LMA - Caution needed

The price of LMA went to a low of $0.35 recently after the profit guidance announcement. For those who bought at $0.35, well done. I suppose there will be a rebound after the initial shock. However, i would urge caution for investors who feel that it is a good buy at current price due to low P/E or low price to cash flow or other financial ratios.

The point i want to make is on the qualitative aspect of the company.
1) For those who bother to read up on the IPO prospectus again, you will find that the IPO is actually an exit strategy for many of its pre-IPO investors. Nearly 90% of the shares offered are from the selling vendors. Ask yourself why the pre-IPO investors want to cash out from a company holding patents of a widely used product?

2) Potential Conflicts of Interest.
The relationship between Venner, Mr. Gaines-Cooper and Mrs. Gaines-Cooper are described in "Management—Arrangements or Understandings.” In addition, a number of our Directors are directors of companies which supply or manufacture our Products. Mr. Gaines-Cooper, Mrs. Gaines-Cooper and Mr. Curtis-Bennett are directors of Venner Trading and FMT. Mr. Gaines-Cooper is a director of Venner Singapore. The info above is taken from the IPO prospectus but they still exist till today.

3) Low sustainable competitive advantage in LMA's patent.
The original master patent relating to the basic design of the LMA-Classic™ airway device and the later single-use version of it, the LMA-Unique™ airway device, expired in December 2002. However, LMA hold or have applied for patents for features in their products.They include the aperture bars in use on the LMA-Classic™, LMAProSeal™ and LMA-Flexible™ devices and the LMA-Fastrach™ handle. Our aperture bar patent protection does not extend to the United States. In my opinion, the patents are not valuable as the competitors can always substitute the features will something else. In short, expiration of patents + low technology product will cause an influx of competitors. Sad to say, the airway product is no longer exclusive. It is becoming a commodity and thus, usually the company with the lowest cost will survive.

4) Over the years, LMA has spent a sizeable amount of cash to buy innovative products, intellectual property rights and distribution companies in its bid to boost the earnings. Please look at my earlier posting to understand why we should generally avoid companies with continued capital investments.

Cheers!